Javascript must be enabled to continue!
From Acid Reflux to Health Hazard: The Growing Cancer Threat Associated with Ranitidine
View through CrossRef
Ranitidine is a medication used for heart burn,
stomach ulcer, gastroesophageal reflux disorder
and other conditions that cause an accumulation of
stomach acid. The side/adverse effects of ranitidine
use include CNS disturbance such as dizziness and
vomiting, nausea. Other reported side effects
include cholestatic hepatitis, hematologic disorders
such as leucopenia, and granulocytopenia,
respiratory effects, and musculoskeletal
complications.
It is an H2 histamine blocker drug. Recently some
studies have found that ranitidine may containthe
presence of potentially carcinogenic compounds
such as N-Nitrosodimethylamine. The purpose of
this study was to assess the relationship between
ranitidine consumption and gastrointestinal cancer.
Proton pump inhibitor (PPI) ana H2 antagonistrelated events that were reported to the FDA
Adverse Events Reporting System were chosen. To
compare the percentage of all reported adverse
events that were for gastrointestinal system
malignancies among ranitidine adverse event
reports to adverse event reports for other H2
antagonists, proportionate reporting ratios (PRRs)
and related 95% confidence intervals were
calculated.Compared to PPIs and other H2
antagonists, ranitidine had a higher percentage of
adverse events for any gastrointestinal system
malignancy relative to all other events (PRR 3.66,
95% Ci 3.19-4.20). Cancers of the pharynx
(PRR 9.24), esophagus (PRR 3.56), stomach (PRR
1.48), colorectal (PRR 16.31), liver (PRR
2.64), and pancreas(PRR 2.18) all had elevated and
substantial PRRs. Although not statistically
significant, the PRRs for gallbladder (PRR 4.62)
and anal (PRR 4.62) cancer were likewise higher.
This discovery is raising concerns about drug
related diseases long-term consumption of
ranitidine may increase the risk of cancerseveral
health authorities have launched an investigation
and recommended its removal from the market. To
make consumer aware in the context and it is
necessary to guide towards safe option.
Title: From Acid Reflux to Health Hazard: The Growing Cancer Threat Associated with Ranitidine
Description:
Ranitidine is a medication used for heart burn,
stomach ulcer, gastroesophageal reflux disorder
and other conditions that cause an accumulation of
stomach acid.
The side/adverse effects of ranitidine
use include CNS disturbance such as dizziness and
vomiting, nausea.
Other reported side effects
include cholestatic hepatitis, hematologic disorders
such as leucopenia, and granulocytopenia,
respiratory effects, and musculoskeletal
complications.
It is an H2 histamine blocker drug.
Recently some
studies have found that ranitidine may containthe
presence of potentially carcinogenic compounds
such as N-Nitrosodimethylamine.
The purpose of
this study was to assess the relationship between
ranitidine consumption and gastrointestinal cancer.
Proton pump inhibitor (PPI) ana H2 antagonistrelated events that were reported to the FDA
Adverse Events Reporting System were chosen.
To
compare the percentage of all reported adverse
events that were for gastrointestinal system
malignancies among ranitidine adverse event
reports to adverse event reports for other H2
antagonists, proportionate reporting ratios (PRRs)
and related 95% confidence intervals were
calculated.
Compared to PPIs and other H2
antagonists, ranitidine had a higher percentage of
adverse events for any gastrointestinal system
malignancy relative to all other events (PRR 3.
66,
95% Ci 3.
19-4.
20).
Cancers of the pharynx
(PRR 9.
24), esophagus (PRR 3.
56), stomach (PRR
1.
48), colorectal (PRR 16.
31), liver (PRR
2.
64), and pancreas(PRR 2.
18) all had elevated and
substantial PRRs.
Although not statistically
significant, the PRRs for gallbladder (PRR 4.
62)
and anal (PRR 4.
62) cancer were likewise higher.
This discovery is raising concerns about drug
related diseases long-term consumption of
ranitidine may increase the risk of cancerseveral
health authorities have launched an investigation
and recommended its removal from the market.
To
make consumer aware in the context and it is
necessary to guide towards safe option.
Related Results
Development and validation of high‐performance liquid chromatography‐Orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction
Development and validation of high‐performance liquid chromatography‐Orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction
Rationale
N
‐Nitroso dimethylamine (NDMA) is a mutagenic impurity detected in several ranitidine products. The amin...
Effectiveness Of Ranitidine Providing Compared With Omeprazol In Children With Gastroesofageal Reflux Disease
Effectiveness Of Ranitidine Providing Compared With Omeprazol In Children With Gastroesofageal Reflux Disease
Background. The drugs that are often given to children with GERD are stomach acidsuppressants, namely the H2 receptor antagonist and proton pump inhibitor (PPI) classof drugs, but ...
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan
Polypharmacy may be considered as the customary practice to provide optimum care services to patients but inter resulted in augmented probability of multiple drug interaction. Keep...
Pendekatan Diagnostik Refluks Laring Faring
Pendekatan Diagnostik Refluks Laring Faring
Abstract: Lifestyle and behavior changes can have bad impacts on our health. One of the diseases that can be caused by lifestyle changes is pharyngeal larynx reflux. Pharyngeal lar...
Comparison of 1‐week vs. 2‐ or 4‐week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
Comparison of 1‐week vs. 2‐ or 4‐week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
Background: Helicobacter pylori eradication therapies based on ranitidine bismuth citrate have recently been introduced in clinical practice.Aim:To compare the efficacy of three re...
SYNERGISTIC DRUG-DRUG INTERACTION;
SYNERGISTIC DRUG-DRUG INTERACTION;
Introduction: Ranitidine is known to us all as an anti-ulcer drug which acts byblocking H2 receptors in the stomach parietal cells. However its role in this category has beenunders...
The role of psychological distress in laryngopharyngeal reflux patients: a prospective questionnaire study
The role of psychological distress in laryngopharyngeal reflux patients: a prospective questionnaire study
Clin. Otolaryngol. 2010, 35, 25–30.Objectives: To determine the role of psychological distress in laryngopharyngeal reflux patients and evaluate the correlation between symptoms, ...
Prevalence of Esophagitis in Patients With pH‐Documented Laryngopharyngeal Reflux
Prevalence of Esophagitis in Patients With pH‐Documented Laryngopharyngeal Reflux
AbstractObjective To report the prevalence of esophagitis in patients with pH‐documented laryngopharyngeal reflux.Study Design Prospective study of 58 consecutive patients with doc...

